May 8, 2020 / By Kayla Rivas | Fox News The U.S. Food and Drug Administration has issued an Emergency Use Authorization (EUA) for a rapid diagnostic, gene-editing tool in detecting the coronavirus. The Cambridge, Mass.-based engineering biology company, Sherlock Biosciences, developed a “CRISPR SARS-CoV-2 kit” to detect the virus in about one hour. “While it has only …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone